The Business Development Workshop and Forum has kicked off in Adelaide, with delegates keen to understand the changing landscape of licensing deal collaborations and what it means for business development in biotechnology companies. [ + ]

Preliminary results of a phase Ib/IIa trial of Biotron’s BIT225 treatment candidate show it can target HIV in cells which mature into ongoing reservoirs for the virus. [ + ]

The genome of an extinct Australian frog has been revived and reactivated by a team of scientists using sophisticated cloning technology to implant a ‘dead’ cell nucleus into a fresh egg from another frog species. The effort has been dubbed ‘the Lazarus Project’. [ + ]

Biolife Science has signed on Pevion Biotech to manufacture its HER-Vaxx anticancer vaccine in preparation for phase II trials in gastric cancer. [ + ]

Combating the global scourge of fake medicines that threatens the health of millions of people is the focus of a landmark agreement between INTERPOL and 29 of the world’s largest pharmaceutical companies. [ + ]

It looks like the particle discovered at the Large Hadron Collider last year is an elusive Higgs boson but whether this is the Higgs boson of the Standard Model of particle physics, or possibly the lightest of several bosons predicted in some theories that go beyond the Standard Model, has yet to be established. [ + ]

Starpharma (ASX:SPL) has signed a crop protection collaboration covering the use of its dendrimer nanotechnology platform technology by Makhteshim Agan. [ + ]

Scientists working in rural Tanzania have used a simple US$8 glass lens, a strip of double-sided tape and a cheap flashlight to convert an Apple iPhone into a field microscope that can successfully detect intestinal worm infections in children. [ + ]

The 15th selection round for cooperative research centres will see the government spend $70 million on three new centres. [ + ]

Proving the benefits and cost-effectiveness of animal robots in the treatment of dementia is the focus of a Griffith research study. [ + ]

Bioengineers from the University of California, San Diego have found that an injectable hydrogel can repair the damage caused by heart attacks. [ + ]

In Spiderman 2, the superhero uses his webbing to bring a runaway train to a standstill moments before it plummets over the end of the track. But could a material with the strength and toughness of spiders’ web really stop four crowded train carriages? [ + ]

With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. [ + ]

Novogen has signed a collaborative agreement with the Ingham Institute to begin progressing its pipeline of cancer therapies. [ + ]

Imugene (ASX:IMU) will receive a Japanese patent that will allow it to explore developing products to treat bone loss using its Linguet drug delivery platform. [ + ]